Clinical Trials Browser

Phase 3 × Behavior Therapy × 90 days × Clear all

NCT04829539 2026-04-24

BBT-II

Phase 3 Active not recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT01503632 2026-04-08

Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission

Phase 3 Completed

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma